4//SEC Filing
CYTORI THERAPEUTICS, INC. 4
Accession 0001140361-15-041223
$PSTVCIK 0001095981operating
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:07 PM ET
Size
5.8 KB
Accession
0001140361-15-041223
Insider Transaction Report
Form 4
HARRIS JOHN DAVID
VP and GM Cell Therapy
Transactions
- Award
Stock Option (Right to Buy)
2015-11-11+335,000→ 335,000 totalExercise: $0.37From: 2016-11-11Exp: 2025-11-11→ Common Stock (335,000 underlying)
Footnotes (2)
- [F1]The reporting person received an NQ stock option granted under the Corporation's 2014 Equity Incentive Plan. The exercise price per share to be paid by the reporting person at the time the option is exercised shall be the closing sale price of the Corporation's Common Stock on the NASDAQ Stock Market as of the date of the grant. The closing sale price is $0.3701.
- [F2]Twenty five percent (25%) of the option shares shall vest on November 11, 2016 with the remaining option shares vesting in 36 equal monthly installments thereafter.
Documents
Issuer
CYTORI THERAPEUTICS, INC.
CIK 0001095981
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001095981
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 5:07 PM ET
- Size
- 5.8 KB